ANTIPROLIFERATIVE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
    7.
    发明申请
    ANTIPROLIFERATIVE COMPOUNDS, COMPOSITIONS AND METHODS OF USE 审中-公开
    抗生素化合物,组合物和使用方法

    公开(公告)号:US20100279990A1

    公开(公告)日:2010-11-04

    申请号:US12308299

    申请日:2007-06-08

    摘要: The present invention provides a compound of the formula A-L-B (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, wherein A is a psychotropic derivative; L is a linking group comprising two carbon atoms; and B is an alkyl, alkenyl, alkynyl or aralkyl comprising at least one substituent of the formula Q, wherein: the alkyl, alkenyl, alkynyl or aralkyl is optionally substituted with one or more halogens, hydroxyl, cyano, nitro, amino or thiol; and Q is OR6, OC(O)R6, C(O)R6 C(S)R6, CO2R6, C(O)SR6, C(O)NR6R7, C(S)NR6R7, NR6R7, NR6C(O)R7, NR6C(S)R7, NR6C(O)NR7R8, NR6C(S)NR7R8, NR6SO2R7, NR6SO2NR7R8, SR6, SC(O)R6, SC(O)NR6R7, S(O)R6, SO2R6, SO2NR6R7, or NR6SO2R7R8. Also provided is a pharmaceutical composition that includes one or more compounds of the present invention, and methods of therapeutically using and processes for producing such compounds and compositions.

    摘要翻译: 本发明提供式A-L-B(I)化合物或其药学上可接受的盐,酯或前药,其中A是精神药物衍生物; L是包含两个碳原子的连接基团; 并且B是包含至少一个式Q取代基的烷基,烯基,炔基或芳烷基,其中:烷基,烯基,炔基或芳烷基任选被一个或多个卤素,羟基,氰基,硝基,氨基或硫醇取代; 并且Q是OR 6,OC(O)R 6,C(O)R 6 C(S)R 6,CO 2 R 6,C(O)SR 6,C(O)NR 6 R 7,C(S)NR 6 R 7,NR 6 R 7,NR 6 C(O) NR 6 C(O)NR 6 R 7,NR 6 C(O)NR 7 R 8,NR 6 C(S)NR 7 R 8,NR 6 SO 2 R 7,NR 6 SO 2 NR 7 R 8,SR 6,SC(O)R 6,SC(O)NR 6 R 7,S(O)R 6,SO 2 R 6,SO 2 NR 6 R 7或NR 6 SO 2 R 7 R 8。 还提供了包含一种或多种本发明化合物的药物组合物,以及治疗用途的方法和制备这些化合物和组合物的方法。

    PSYCHOTROPIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE
    8.
    发明申请
    PSYCHOTROPIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE 审中-公开
    心理化合物,组合物和使用方法

    公开(公告)号:US20100130549A1

    公开(公告)日:2010-05-27

    申请号:US12522637

    申请日:2008-01-10

    摘要: The present invention provides a method for treating or preventing a disease or disorder treatable by the inhibition of serotonin reuptake in a patient, and/or norepinephrine reuptake and/or dopamine reuptake in a patient, the method comprising administering to the patient a neurotransmitter reuptake inhibiting-effective amount of at least one compound of the formula A-L-B (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, wherein A is a psychotropic derivative; L is a linking group comprising two carbon atoms; and B is an alkyl, alkenyl, alkynyl or aralkyl comprising at least one substituent of the formula Q, wherein: the alkyl, alkenyl, alkynyl or aralkyl is optionally substituted with one or more halogean halogens, hydroxyl, cyano, nitro, amino or thiol; and Q is OR6, OC(O)R6, C(O)R6, C(S)R6, CO2R6, C(O)SR6, C(O)NR6R7, C(S)NR6R7, NR6R7, NR6C(O)R7, NR6C(S)R7, NR6C(O)NR7R8, NR6C(S)NR7R8, NR6SO2R7, NR6SO2NR7R8, SR6, SC(O)R6, SC(O)NR6R7, S(O)R6, SO2R6, SO2NR6R7, or NR6SO2NR7R8.

    摘要翻译: 本发明提供了一种治疗或预​​防通过抑制患者血清素再摄取和/或去甲肾上腺素再摄取和/或患者多巴胺再摄取而可治疗的疾病或病症的方法,所述方法包括向患者施用神经递质再摄取抑制 - 有效量的至少一种式ALB(I)化合物或其药学上可接受的盐,酯或前药,其中A是精神药物衍生物; L是包含两个碳原子的连接基团; 并且B是包含至少一个式Q取代基的烷基,烯基,炔基或芳烷基,其中:烷基,链烯基,炔基或芳烷基任选被一个或多个卤代卤素,羟基,氰基,硝基,氨基或硫醇取代 ; (O)R 6,C(O)R 6,C(O)SR 6,C(O)NR 6 R 7,C(S)NR 6 R 7,NR 6 R 7,NR 6 C(O)R 7 ,NR6C(S)R7,NR6C(O)NR7R8,NR6C(S)NR7R8,NR6SO2R7,NR6SO2NR7R8,SR6,SC(O)R6,SC(O)NR6R7,S(O)R6,SO2R6,SO2NR6R7或NR6SO2NR7R8。